Skip to main content
. 2009 Mar 2;106(12):4617–4622. doi: 10.1073/pnas.0900191106

Fig. 6.

Fig. 6.

MTAP is a protein target for the IPL ligand Pro-AP1780. (A) Validation with Western blot analysis of MTAP in IPL pull-downs and cell lysate. (B) In vitro MTAP activity assay with 3 dose levels of each IPL ligand. All IPL ligands show slight inhibition of MTAP at the highest levels of compound dose (850 μM). Pro-AP1780 shows the largest inhibitory effect on MTAP in comparison with DMSO treated controls.